Skip to main content
Erschienen in: Journal of Translational Medicine 1/2022

Open Access 01.12.2022 | Research

Monophosphoryl lipid A ameliorates radiation-induced lung injury by promoting the polarization of macrophages to the M1 phenotype

verfasst von: Xingdong Guo, Lehui Du, Na Ma, Pei Zhang, Yuan Wang, Yanan Han, Xiang Huang, Qian Zhang, Xin Tan, Xiao Lei, Baolin Qu

Erschienen in: Journal of Translational Medicine | Ausgabe 1/2022

Abstract

Background

Radiation-induced lung injury (RILI) often occurs during clinical chest radiotherapy and acute irradiation from accidental nuclear leakage. This study explored the role of monophosphoryl lipid A (MPLA) in RILI.

Materials and Methods

The entire thoracic cavity of C57BL/6N mice was irradiated at 20 Gy with or without pre-intragastric administration of MPLA. HE staining, Masson trichrome staining, and TUNEL assay were used to assess lung tissue injury after treatment. The effect of irradiation on the proliferation of MLE-12 cells was analyzed using the Clonogenic assay. The effect of MPLA on the apoptosis of MLE-12 cells was analyzed using flow cytometry. Expression of γ-H2AX and epithelial-mesenchymal transition (EMT) markers in MLE-12 cells was detected by immunofluorescence and Western blot, respectively.

Results

MPLA attenuated early pneumonitis and late pulmonary fibrosis after thoracic irradiation and reversed radiation-induced EMT in C57 mice. MPLA further promoted proliferation and inhibited apoptosis of irradiated MLE-12 cells in vitro. Mechanistically, the radioprotective effect of MPLA was mediated by exosomes secreted by stimulated macrophages. Macrophage-derived exosomes modulated DNA damage in MLE-12 cells after irradiation. MPLA promoted the polarization of RAW 264.7 cells to the M1 phenotype. The exosomes secreted by M1 macrophages suppressed EMT in MLE-12 cells after irradiation.

Conclusion

MPLA is a novel treatment strategy for RILI. Exosomes derived from macrophages are key to the radioprotective role of MPLA in RILI.
Hinweise
Xingdong Guo, Lehui Du and Na Ma contributed equally to this work

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Radiation-induced lung injury (RILI) is one of the most common complications caused by thoracic radiotherapy [1]. Patients receiving radiation therapy, workers in nuclear power plants, or people exposed to high radiation levels as a result of a nuclear accident are at risk of RILI [2]. RILI, accompanied by radiation pneumonitis (RP) and radiation fibrosis, occurs in approximately 5–20% of patients with thoracic radiotherapy, limiting the use of maximum irradiation dose. This results in poor tumor treatment control and may lead to dyspnea, lowering the quality of life of lung cancer patients [3]. RILI can activate the production of various cytokines, infiltration of inflammatory cells, fibroblasts, and tissue remodeling, ultimately impairing lung function and causing respiratory failure [4]. So far, amifostine is the only drug approved by FDA for radioprotection. However, due to its adverse side effects, such as vomiting, nausea and hypotension, it is not routinely used clinically. Therefore, the development of new therapeutic drugs is of great significance.
Toll-like receptors (TLRs) are type I transmembrane proteins that mediate the recognition of pathogen-associated molecular patterns (PAMPs). So far, 10 and 12 functional TLRs have been found in humans and mice, respectively [5]. TLRs are essential human innate immunity receptors that participate in certain immune responses and immune-related disorders. Irradiation (IR) strongly activates TLRs in human cells [6]. In recent years, numerous studies have demonstrated the protective effects of TLRs against IR. Kutikhin et al. [7] revealed that TLRs (TLR4, TLR7, TLR8, and TLR9) participate in DNA repair. Burdelya et al. [8] demonstrated that CBLB502, a TLR5 activation agonist, alleviates acute radiation syndrome and improves the survival of mice after radiation exposure. Collectively, the reports indicated that TLRs play essential radiative roles.
Monophosphoryl lipid A (MPLA) is a TLR4 agonist that is 10,000 times less toxic than Lipopolysaccharide (LPS) [9, 10]. Guo et al. [11] demonstrated that MPLA protects the intestines against ionizing radiation damage by activating the TLR4 signaling pathway. A related study [12] revealed that macrophage-derived exosomes stimulated by MPLA played an essential role in protecting the testis against radiation. Epithelial-mesenchymal transition (EMT) plays a vital role in RILI [13]. Polydatin alleviates RILI by inhibiting EMT [14]. Reversing EMT may alleviate RILI. In the present study, we demonstrated that MPLA effectively ameliorated radiation injury and inflammation in lung tissues. MPLA reverses EMT via macrophage-derived exosomes. Thus, MPLA is a promising option for treating RILI.

Materials and methods

Irradiation of animals

Adult male C57BL/6N mice (6–8-week-old, 18‐20 g) were purchased from Vital River Experimental Animal Company (Beijing, China). The protocols for animal experiments were approved by the Animal Care and Use Committee of the Academy of Military Medical Sciences (Beijing, China). The mice were maintained in rooms under a 12-h light/dark cycle, 20–26 °C, and at a relative humidity of 40–70%. The mice were acclimatized for one week and were fed enough food and water before the experiments.
Before irradiation, the mice were randomly divided into four groups as follows: normal control (CON group); MPLA without irradiation group (MPLA group); irradiation only group (IR group), and irradiation plus MPLA group (MPLA + IR group). MPLA was purchased from InvivoGen (Lot: 5978–42-01). Based on our previous research results[12], mice in the MPLA + IR group and MPLA group were injected intragastrically with 50 μg/kg MPLA dissolved in 0.1 mL phosphate buffer saline 12 h before irradiation. Mice in the IR group were injected with 0.1 mL phosphate buffer saline. In the previous research, the RILI model has been successfully constructed and verified many times [15]. Mice were then anesthetized by intraperitoneal injection with 1% pentobarbital sodium (50 mg/kg body weight) before thoracic irradiation (20 Gy) with a 60Co γ-ray (Beijing Institute of Radiation) at a rate of 60.87 cGy/min. Except for the thorax, the other parts of the mice were covered with 10-cm-thick lead bricks.Lung tissue samples were collected at weeks 1, 4, 8, and 16 after radiation.

Cell culture and treatment

The mice alveolar epithelial cell (MLE‐12), the mice monocyte cell line (RAW 264.7) and the human lung epithelial cell (Beas-2B) were obtained from Otwo Biotech (Shenzhen, China). The cells were cultured in DMEM medium (10% fetal calf serum) at 37 °C in a 5% CO2 humidified chamber. MLE-12 cells were radiated at dose of 8 Gy (clonogenic assay with 0 Gy, 2 Gy, 4 Gy, and 8 Gy) [16].

Conditioned culture

We used different culture supernatants as a conditioned medium to observe their effects on MLE-12 cells. We cultured the RAW 264.7 cells when the confluence was approximately 50–60%, replaced the original medium with DMEM medium, and continued to cultivate for 12 h. After this, we collected the supernatants and centrifuged them for 10 min at 2000 rpm, collected the supernatant as RAWsup; We added 1 µg/mL MPLA to the medium DMEM medium, then maintained cultured RAW264.7 cells for an additional 12 h. Next, collected the supernatants and centrifuged them for 10 min at 2000 rpm, the supernatant was MPLAsup; Unlike MPLAsup, we cultured RAW264.7 for 2 h with a medium containing GW4689 of 20 μM concentration before using MPLA [17, 18], the following steps were the same as the MPLAsup, we collected the supernatant as (GW4869 + MPLA)sup.

Clonogenic assay

The cell proliferation potential was assessed based on the survival rate of the clones. Specific number of cells was seeded in 6-well plates and irradiated with 0 Gy, 2 Gy, 4 Gy, and 8 Gy. After 7–10 days of incubation, the plates were fixed with paraformaldehyde, stained with 1% crystal violet for 30 min, washed with PBS, and colonies (≥ 50 cells as a colony) counted under a dissecting microscope. The surviving fraction (SF) curve was based on the multi-target single-hit model.

Apoptosis analysis

FITC Annexin V Apoptosis Detection Kit I (BD Pharmingen) was used for analysising cell appotosis. After different experimental conditions, the MLE-12 cells were washed twice with cold PBS and resuspended in 1X Binding Buffer at 1 × 106 cells/mL. Thereafter, 100 μL of the solution (1 × 105 cells) was transferred into a 5 mL culture tube before adding 5 μL of FITC Annexin V and 5 μL of PI. The cells were gently vortexed and incubated for 15 min at 25 °C in the dark. Then, 400 μL of 1X Binding Buffer was added to each tube. Apoptosis rate analysis was performed within 1 h using flow cytometry.

Western blot analysis

Protein extracts were prepared from a different group of MLE-12 cells. The samples were incubated for 2 h with primary antibodies against TLR4 (proteintech, 1:5000), γ-H2AX (Cell Signaling Technology; 1:1000), E-cadherin (Cell Signaling Technology, 1:1000), Vimentin (Cell Signaling Technology, 1:1000), and α-SMA (Cell Signaling Technology, 1:1000) in 5% nonfat milk. The samples were then incubated with HRP-conjugated IgG (proteintech, 1:5000) for 1 h.

Immunofluorescence staining

Immunofluorescence assay was used to detect the number of γ-H2AX foci. Cells were seeded in 24-well plates. After washing with PBS, cells were fixed in 3% paraformaldehyde and permeabilized in 0.1% Triton X-100 in PBS. The cells were then stained with γ-H2AX primary antibody (Cell Signaling Technology; 1:200) and thereafter the secondary antibody (fluorescein goat anti-rabbit IgG, Invitrogen; 1:1000). Cells were stained with a DAPI (Antifade Mounting Medium with DAPI, Beyotime). The images were captured using an Olympus BX60 fluorescent microscope (Olympus America Inc).

Enzyme-linked immunosorbent assay

The serum levels of tumor necrosis factor-alpha (TNF-α), transforming growth factor-β (TGF-β), IL-1β, and IL-10 were measured using ELISA, following the manufacturer’s instructions (BOSTER).

TLR4 expression and GO analysis

Data for TLR4 expression were downloaded from the TCGA and GTEx databases (http://​gepia2.​cancer-pku.​cn/​#index). GO analysis was analyzed with the R software.

Statistical analysis

All quantitative data were presented as the mean ± standard error of the mean (SEM). All experiments were performed in 3 independent replicates. Differences between two groups were analyzed using the t-test, while differences among multiple groups were analyzed using the one-way ANOVA and Tukey’s test. Statistical significance was set at 5%. All statistical analyses were two-sided, and data were analyzed using the Prism 9.0 software (GraphPad).

Results

MPLA alleviated IR-induced lung injury in mice

MPLA plays a critical radioprotective role in many tissues except the lung. To investigate the radioprotective effect of MPLA on mice lung tissue, the thoracic regions of mice were irradiated and analyzed. After 20 Gy local irradiation, the infiltration of cells was observed at weeks 1 and 4, and alveolar septal thickening was observed primarily at weeks 8 and 16 by Hematoxylin staining. Compared with the single irradiation group, radiation-induced inflammation and alveolar wall thickening were significantly lower in the MPLA + IR group (Fig. 1A–D). Quantitative analysis showed that MPLA modulated radiation-induced pneumonitis (Fig. 1E).
Advanced pulmonary RILI is mainly characterized by excess fibrosis [19]. Masson’s trichrome staining revealed that collagen deposition increased from 1-week to 16-week post-irradiation. Compared with the single irradiation group, collagen deposition induced by radiation in the MPLA + IR group was significantly low (Fig. 1A–D). Quantitative analysis showed that MPLA inhibited radiation-induced collagen deposition and pulmonary fibrosis (Fig. 1F).
TUNEL assay is a critical method for quantifying IR-Induced apoptosis in mice lungs. The apoptosis rate was analyzed using respective markers. The results showed that the MPLA significantly reduced the apoptosis of alveolar epithelial cells after radiation (Fig. 1A–D). The quantitative analysis presented as Fig. 1G.
Lung coefficient (lung weight/body weight) indicates the degree of pulmonary edema and high vascular permeability. We found that MPLA treatment restored normal lung weight after irradiation (Fig. 1H), suggesting that MPLA prevents RILI in vivo.

MPLA reversed radiation-induced EMT in mice

There is a close relationship between radiation-induced EMT and pulmonary fibrosis. The expression of EMT markers reflects the EMT severity [20, 21]. In the present study, the expression of EMT markers (E-cadherin and vimentin and α-SMA) in the epithelial lung cells were analyzed by immunofluorescence staining. The results showed that E-cadherin expression was downregulated in the IR group. In contrast, vimentin and α-SMA expression were upregulated in the alveolar epithelium after irradiation. However, MPLA inhibited the downregulated E-cadherin expression induced by radiation and inhibited the overexpression of α-SMA and vimentin in (Fig. 2A–D). Quantitative analysis revealed that irradiation reduced the expression of E-cadherin, but MPLA treatment reversed this phenomenon (Fig. 2E). MPLA inhibited the expression of vimentin and α-SMA in irradiated lung tissues (Fig. 2F–G). This result indicated that MPLA ameliorated radiation-induced EMT in mice lung tissue.

MPLA promoted the proliferation of MLE-12 cells

Our experiments demonstrated the radioprotective effect of MPLA on mice lung tissue in vivo. In vitro experiments were performed to explore whether MPLA also has a radioprotective effect on mice lung epithelial cells. We tested the toxicity of MPLA on MLE-12 cells from a concentration range from 0 to 50 μg/mL. Cytotoxicity test showed that a concentration of 0 to 10 μg/mL of MPLA was non-toxic to MLE-12 cells (Fig. 3A). In previous studies, we demonstrated that MPLA at a concentration of 1 μg/mL played an effective role in radiation protection [12]. Therefore, 1 μg/mL of MPLA was used in the subsequent experiments. MPLA is a TLR4-specific agonist. Previous studies using mice models have shown that MPLA protects against ionizing radiation damage to intestines by activating the TLR4 signaling pathway [11]. Interestingly, ionizing radiation modulates the expression of TLR4 in the lung tissue [12]. The data from TCGA and GTEx databases showed that the expression of TLR4 was higher in normal lung tissue than in tumor tissue (Fig. 3B). In the present study, the expression of TLR4 in MLE-12 cell, Beas-2B cell, and macrophage RAW264.7 was analyzed using the Western blot assay. We found that TLR4 expression was very low in MLE-12 and Beas-2B cells with or without MPLA treatment and radiation treatment. While TLR4 was highly expressed in RAW264.7 cells particularly after radiation, MPLA treatment did not upregulate TLR4 expression in RAW264.7 cells (Fig. 3C, D). Considering the differential expression of TLR4 in different cell types of the lung tissue, we assessed whether MPLA, a TLR4 agonist, directly enhanced the survival and alleviated irradiation-induced damage on MLE-12 cells or by activating macrophages (highly expressed TLR4). Then we subjected a clonal formation assay, as we could see, the supernatant of RAW264.7(RAWsup group) had no radiation protection effect against MLE-12, but it significantly reduces cell death after irradiation in the MPLAsup group(Fig. 3E). The “multi-target-single-hit model” showed that MPLA has no direct radioprotective effect on MLE-12 cells (Fig. 3F). Previous studies have shown that macrophage-derived exosomes in the testis are radioprotective [12]. The biological functions and pathways regulated by TLR4 were explored by functional enrichment analysis using data from the TCGA database. The GO results showed that TLR4 activity was enriched in exosome-related terms, such as secretory granule membrane (Fig. 3G). Therefore, RAW264.7 was treated with GW4869 (an inhibitor of exosome biogenesis/release) for 2 h before MPLA. Surprisingly, clonal formation assay revealed no significant radio-protection effect between the GW4869 + MPLA and the MPLAsup group (Fig. 3H, I). These results implied that MPLA protected lung tissues against irradiation damage by stimulating macrophages to produce exosomes.

Macrophage-derived exosomes inhibited MLE-12 cell apoptosis

A previous study demonstrated that thoracic irradiation stimulated the apoptosis of Type II Alveolar Epithelial Cells (AECIIs) [22]. In the present study, we explored the effect of MPLA on the apoptosis of MLE-12 cells after irradiation using flow cytometry. The experimental result proves that the total number of apoptosis detected in MPLAsup group was significantly less than that in groups NC and MPLA (Fig. 4A, B). Next, we inhibited exosomes with GW4869, surprisingly, in (GW4869 + MPLA)sup group, the inhibition of apoptosis was barely observed (Fig. 4C, D). This result suggests that macrophage-derived exosomes play a key role in MPLA-mediated radioprotection.

Macrophage-derived exosomes alleviated DNA damage in MLE-12 cells

IR induces breakage of double-stranded DNA breaks and the subsequent apoptosis of corresponding cells. In the present study, we used γ-H2AX expression as an indicator of double-stranded DNA breaks at different time points after irradiation. The result showed that γ-H2AX overexpressed in CON group at 1 h after irradiation and partially recovered at 8 h after irradiation. γ-H2AX expression in MPLAsup group at 1 h and 8 h after radiation was significantly lower than that in the CON group (Fig. 5A, C). This experiment illuminated that MPLAsup alleviated radiation-induced DNA damage. Identically, we then used GW4869 to inhibit the exosomes from macrophage stimulated by MPLA, there was no significant difference in γ-H2AX expression between group (GW4869 + MPLA)sup and group CON, whether it was 1 h or 8 h (Fig. 5B, D). Then, we detected the γ-H2AX foci by immunofluorescence method, numbers of γ-H2AX foci were much higher in IR group compared to MPLAsup group, the (GW + MPLA)sup group had no significant difference to the IR group (Fig. 5E, F). Overall, the results showed that macrophage-derived exosomes alleviated DNA damage in MLE-12 cells.

Exosomes derived from classically activated M1 macrophage suppress EMT

Classically activated M1 macrophages promote inflammation and inhibit fibrosis, while alternatively activated M2 macrophages modulate inflammation and promote fibrosis [23, 24]. Lipopolysaccharide (LPS) induces M1 polarization of macrophages [25, 26]. To clarify the effect of MPLA on macrophage polarization, RAW264.7 cells were cultured in media supplemented with MPLA. The supernatant was collected after 12 h of culture to analyze the expression levels of TNF-α, TGF-β, IL-1β, and IL-10. We found that TNF-α and IL-1β were over secreted, suggesting that MPLA stimulated M2 polarization of RAW264.7 cells (Fig. 6A–D).
Irradiation induces EMT of epithelial cells following pulmonary fibrosis [27]. Our results showed that the expression of the epithelial marker E-cadherin was decreased and the expression of the mesenchymal markers Vimentin and α-SMA was upregulated after irradiation. However, the overexpression of α-SMA and Vimentin was inhibited in the MPLAsup group. Meantime, the downregulation of epithelial markers E-cadherin was inhibited in the MPLAsup group. There were no differences in the GW + MPLAsup group compared with the IR group(Fig. 6E–H). In conclusion, our experiments demonstrated that macrophage-derived exosomes can attenuate RILI. The radiation protection effect might be related to inhibition of EMT process.

Discussion

This study showed that MPLA inhibited or ameliorated RILI by stimulating the production of exosomes by macrophages. The research demonstrated that MPLA could reduce lung tissue damage after irradiation, suggesting that MPLA had a specific inhibitory effect on early pneumonia of RILI. Furthermore, the apoptosis of lung epithelial cells was significantly reduced after irradiation. Next, we found that MPLA attenuated radiation-induced lung fibrosis at 16-week post-radiation. Moreover, the results showed that MPLA reversed lung epithelial cell EMT. After confirming the radiation protective effect of MPLA in vivo, we tried to explore the radiation protective mechanism of MPLA in vitro. Considering the low expression of TLR4 in normal lung cells and high expression of TLR4 in macrophages, the radiation protection effect of MPLA might be related to macrophage-derived exosomes. Then we used clonogenic assays to demonstrate that macrophage-derived exosomes promote the proliferation of MLE-12 cells after irradiation. These results interested us so that we did the futher assays. Then we illuminated that MPLA stimulated macrophages to M1-type polarization, secretes exosomes and ameliorates RILI.The potential mechanism of MPLA in RILI is shown in Fig. 7(By Figdraw).To sum up, MPLA is a novel drug that protect against RILI.
Ionizing radiation induces the differentiation of lung fibroblasts to differentiate into myofibroblasts [2830]. Myofibroblasts cause excessive deposition of extracellular matrix and abnormal remodeling, leading to RILI by promoting collagen synthesis [31]. TLRs mediate resistance to irradiation in multiple animal tissues [32], including testicular tissue, intestinal epithelium, and other tissues and organs [11, 12]. TLR4 also protects against RILI. A previous study showed that both TLR2 and TLR4 enhance radiation-induced fibrosis in mice [33]. Another study showed that HKST, an agonist of TLR2, TLR4, and TLR5, ameliorated RILI [14]. However, the expression of TLR4 varies between different human tissues, which explains the variation in radioprotective effects. TLR4 is underexpressed in the testis tissues and highly expressed in the spleen tissues. Macrophage-derived exosomes exert radioprotective effects on the testis [12], suggesting that TLRs could alleviate RILI. The mechanism by which TLRs alleviate radiation-induced damage is unclear and needs further exploration. In this study, we found that MPLA protects against IR damage to lung tissue. However, TLR4 expression in lung tissue and lung alveolar epithelial cells is very low. We demonstrated that MPLA reduces radiation-induced cell apoptosis and promotes the proliferation of lung epithelial cells by stimulating the secretion of exosomes in macrophage. Meanwhile, analysis of data in the TCGA revealed that TLR4 expression was significantly lower in lung tumor tissue in normal lung tissue.
Recent studies have shown that EMT plays an essential role in the development of radiation-induced pulmonary fibrosis [13]. Research has shown that reversing EMT can reduce RILI. For instance, Re-Du-Ning ameliorated radiation pneumonitis by inhibiting EMT [34]. ECM-derived hydrogels prevent RILI by modulating EMT [35]. Polydatin alleviates RILI by inhibiting EMT [36]. Herein, an in vitro experiment revealed that MPLA promotes the polarization of RAW 264.7 cells towards M1 phenotype. Studies have demonstrated that M1 macrophages promote inflammation and inhibits fibrosis [23]. Interestingly, LPS treatment (induces macrophage polarization to M1 type) attenuates early radiation damage to the lung [37]. Radiation-induced early inflammation plays a minimal role in the later development of pneumonia [38]. TGF-β1 is a specific cytokine that induces extracellular matrix production [39, 40], consistent with our findings. TGF-β promote radiation-induced EMT process [41, 42] Nevertheless, the relationship between TLRs and EMT is not well understood. This study revealed that MPLA promotes the polarization of RAW 264.7 cells towards the M1 phenotype and inhibits TGF-β secretion by macrophages. Moreover, the macrophage-derived exosomes inhibited the radiation-induced EMT.
RILI encompasses any lung toxicity induced by radiation therapy andmanifests acutely as radiation pneumonitis and chronically as radiation pulmonary fibrosis. It is believed that the main mechanism is that when the lung tissue is under radiation, a large amount of reactive oxygen species can be produced, and act on the alveolar epithelial cells and vascular endothelial cells, causing a large number of cells to undergo apoptosis and damage the barrier function of the lung tissue [1, 3]. Therefore, a lot of research has been carried out using natural antioxidants to perevent RILI [43, 44]. Mitochondria, as an important site of ROS and energy metabolism, may play a key role in the prevention of RILI [45]. In addition, exosomes are often used as therapeutic drug carriers in clinical applications [46, 47], with the rise of nanomaterials and the perfection of the principles of nanoparticle design, nanoantioxidants may be able to exert radiation protection by targeting lung tissue specifically [48, 49], which we could combine the purified TLR4-activated macrophage-derived exosomes with nanomaterials for precise treatment of RILI. On the other hand, related studies have shown that statins have significant radioprotective effects, but the mechanism remains unclear. Related studies illuminated macrophages could reduce obesity related inflammation [50, 51]. Therefore, we speculate that the radioprotective effect of macrophages may be related to fat metabolism, which is also one of our next research directions.
In conclusion, MPLA significantly alleviates radiation-induced lung injury by promoting the polarization of macrophages towards the M1 type. The M1 macrophages secrete exosomes that attenuate radiation-induced DNA damage and modulate the secretion of TGF-β that reverses radiation-induced EMT and lung fibrosis. This study demonstrates a novel mechanism for inhibiting or reversing RILI. The findings of this study provide a new perspective for protecting against IR-induced lung damages, either during treatment or accidentally.

Acknowledgements

The authors would like to thank all the reviewers who participated in the review, as well as MJEditor (www.​mjeditor.​com) for providing English editing services during the preparation of this manuscript.

Declarations

Not applicable.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Hanania AN, Mainwaring W, Ghebre YT, Hanania NA, Ludwig M. Radiation-induced lung injury. Chest. 2019;156:150–62.CrossRef Hanania AN, Mainwaring W, Ghebre YT, Hanania NA, Ludwig M. Radiation-induced lung injury. Chest. 2019;156:150–62.CrossRef
2.
Zurück zum Zitat Obrador E, Salvador-Palmer R, Villaescusa JI, Gallego E, Pellicer B, Estrela JM, et al. Nuclear and radiological emergencies: biological effects countermeasures and biodosimetry. Antioxidants. 2022;11:1098.CrossRef Obrador E, Salvador-Palmer R, Villaescusa JI, Gallego E, Pellicer B, Estrela JM, et al. Nuclear and radiological emergencies: biological effects countermeasures and biodosimetry. Antioxidants. 2022;11:1098.CrossRef
3.
Zurück zum Zitat Giuranno L, Ient J, De Ruysscher D, Vooijs MA. Radiation-induced lung injury (RILI). Front Oncol. 2019;9. Giuranno L, Ient J, De Ruysscher D, Vooijs MA. Radiation-induced lung injury (RILI). Front Oncol. 2019;9.
4.
Zurück zum Zitat Xu S, Liu C, Ji H-L. Concise review: therapeutic potential of the mesenchymal stem cell derived secretome and extracellular vesicles for radiation-induced lung injury: progress and hypotheses. Stem Cells Transl Med. 2019;8:344–54.CrossRef Xu S, Liu C, Ji H-L. Concise review: therapeutic potential of the mesenchymal stem cell derived secretome and extracellular vesicles for radiation-induced lung injury: progress and hypotheses. Stem Cells Transl Med. 2019;8:344–54.CrossRef
5.
Zurück zum Zitat Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124:783–801.CrossRef Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124:783–801.CrossRef
6.
Zurück zum Zitat Mehdipour A, Yousefi-Ahmadipour A, Kennedy D, Kazemi AM. Ionizing radiation and toll like receptors: a systematic review article. Hum Immunol. 2021;82:446–54.CrossRef Mehdipour A, Yousefi-Ahmadipour A, Kennedy D, Kazemi AM. Ionizing radiation and toll like receptors: a systematic review article. Hum Immunol. 2021;82:446–54.CrossRef
7.
Zurück zum Zitat Kutikhin AG, Yuzhalin AE, Tsitko EA, Brusina EB. Pattern recognition receptors and DNA repair: starting to put a jigsaw puzzle together. Front Immunol. 2014;5:343.CrossRef Kutikhin AG, Yuzhalin AE, Tsitko EA, Brusina EB. Pattern recognition receptors and DNA repair: starting to put a jigsaw puzzle together. Front Immunol. 2014;5:343.CrossRef
8.
Zurück zum Zitat Burdelya LG, Krivokrysenko VI, Tallant TC, Strom E, Gleiberman AS, Gupta D, et al. An agonist of toll-like receptor 5 Has radioprotective activity in mouse and primate models. Science. 2008;320:226–30.CrossRef Burdelya LG, Krivokrysenko VI, Tallant TC, Strom E, Gleiberman AS, Gupta D, et al. An agonist of toll-like receptor 5 Has radioprotective activity in mouse and primate models. Science. 2008;320:226–30.CrossRef
9.
Zurück zum Zitat Pouliot K, Buglione-Corbett R, Marty-Roix R, Montminy-Paquette S, West K, Wang S, et al. Contribution of TLR4 and MyD88 for adjuvant monophosphoryl lipid A (MPLA) activity in a DNA prime-protein boost HIV-1 vaccine. Vaccine. 2014;32:5049–56.CrossRef Pouliot K, Buglione-Corbett R, Marty-Roix R, Montminy-Paquette S, West K, Wang S, et al. Contribution of TLR4 and MyD88 for adjuvant monophosphoryl lipid A (MPLA) activity in a DNA prime-protein boost HIV-1 vaccine. Vaccine. 2014;32:5049–56.CrossRef
10.
Zurück zum Zitat Edwards DK, Jasny E, Yoon H, Horscroft N, Schanen B, Geter T, et al. Adjuvant effects of a sequence-engineered mRNA vaccine: translational profiling demonstrates similar human and murine innate response. J Transl Med. 2017;15:1.CrossRef Edwards DK, Jasny E, Yoon H, Horscroft N, Schanen B, Geter T, et al. Adjuvant effects of a sequence-engineered mRNA vaccine: translational profiling demonstrates similar human and murine innate response. J Transl Med. 2017;15:1.CrossRef
11.
Zurück zum Zitat Guo J, Liu Z, Zhang D, Chen Y, Qin H, Liu T, et al. TLR4 agonist monophosphoryl lipid A alleviated radiation-induced intestinal injury. J Immunol Res. 2019;2019:1–10. Guo J, Liu Z, Zhang D, Chen Y, Qin H, Liu T, et al. TLR4 agonist monophosphoryl lipid A alleviated radiation-induced intestinal injury. J Immunol Res. 2019;2019:1–10.
12.
Zurück zum Zitat Liu Z, Cao K, Liao Z, Chen Y, Lei X, Wei Q, et al. Monophosphoryl lipid A alleviated radiation-induced testicular injury through TLR4-dependent exosomes. J Cell Mol Med. 2020;24:3917–30.CrossRef Liu Z, Cao K, Liao Z, Chen Y, Lei X, Wei Q, et al. Monophosphoryl lipid A alleviated radiation-induced testicular injury through TLR4-dependent exosomes. J Cell Mol Med. 2020;24:3917–30.CrossRef
13.
Zurück zum Zitat Choi S-H, Hong Z-Y, Nam J-K, Lee H-J, Jang J, Yoo RJ, et al. A Hypoxia-induced vascular endothelial-to-mesenchymal transition in development of radiation-induced pulmonary fibrosis. Clin Cancer Res. 2015;21:3716–26.CrossRef Choi S-H, Hong Z-Y, Nam J-K, Lee H-J, Jang J, Yoo RJ, et al. A Hypoxia-induced vascular endothelial-to-mesenchymal transition in development of radiation-induced pulmonary fibrosis. Clin Cancer Res. 2015;21:3716–26.CrossRef
14.
Zurück zum Zitat Kun C, Tao L, Leiyuan H, Yunhao F, Ning W, Zhe L, et al. Heat-killed Salmonella typhimurium mitigated radiation-induced lung injury. Clin Exp Pharmacol Physiol. 2019;46:1084–91.CrossRef Kun C, Tao L, Leiyuan H, Yunhao F, Ning W, Zhe L, et al. Heat-killed Salmonella typhimurium mitigated radiation-induced lung injury. Clin Exp Pharmacol Physiol. 2019;46:1084–91.CrossRef
15.
Zurück zum Zitat Mathew B, Jacobson JR, Siegler JH, Moitra J, Blasco M, Xie L, et al. Role of migratory inhibition factor in age-related susceptibility to radiation lung injury via NF-E2-related factor-2 and antioxidant regulation. Am J Respir Cell Mol Biol. 2013;49:269–78.CrossRef Mathew B, Jacobson JR, Siegler JH, Moitra J, Blasco M, Xie L, et al. Role of migratory inhibition factor in age-related susceptibility to radiation lung injury via NF-E2-related factor-2 and antioxidant regulation. Am J Respir Cell Mol Biol. 2013;49:269–78.CrossRef
16.
Zurück zum Zitat Xiong S, Pan X, Xu L, Yang Z, Guo R, Gu Y, et al. Regulatory T cells promote β-catenin–mediated epithelium-to-mesenchyme transition during radiation-induced pulmonary fibrosis. Int J Radiat Oncol. 2015;93:425–35.CrossRef Xiong S, Pan X, Xu L, Yang Z, Guo R, Gu Y, et al. Regulatory T cells promote β-catenin–mediated epithelium-to-mesenchyme transition during radiation-induced pulmonary fibrosis. Int J Radiat Oncol. 2015;93:425–35.CrossRef
17.
Zurück zum Zitat Catalano M, O’Driscoll L. Inhibiting extracellular vesicles formation and release: a review of EV inhibitors. J Extracell Vesicles. 2020;9:1703244.CrossRef Catalano M, O’Driscoll L. Inhibiting extracellular vesicles formation and release: a review of EV inhibitors. J Extracell Vesicles. 2020;9:1703244.CrossRef
18.
Zurück zum Zitat Wang G, Xie L, Li B, Sang W, Yan J, Li J, et al. A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis. Nat Commun. 2021;12:5733.CrossRef Wang G, Xie L, Li B, Sang W, Yan J, Li J, et al. A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis. Nat Commun. 2021;12:5733.CrossRef
19.
Zurück zum Zitat Dadrich M, Nicolay NH, Flechsig P, Bickelhaupt S, Hoeltgen L, Roeder F, et al. Combined inhibition of TGFβ and PDGF signaling attenuates radiation-induced pulmonary fibrosis. OncoImmunology. 2016;5: e1123366.CrossRef Dadrich M, Nicolay NH, Flechsig P, Bickelhaupt S, Hoeltgen L, Roeder F, et al. Combined inhibition of TGFβ and PDGF signaling attenuates radiation-induced pulmonary fibrosis. OncoImmunology. 2016;5: e1123366.CrossRef
20.
Zurück zum Zitat Ding N-H, Li J, Sun L-Q. Molecular mechanisms and treatment of radiation-induced lung fibrosis. Curr Drug Targets. 2013;14:1347–56.CrossRef Ding N-H, Li J, Sun L-Q. Molecular mechanisms and treatment of radiation-induced lung fibrosis. Curr Drug Targets. 2013;14:1347–56.CrossRef
21.
Zurück zum Zitat Wang J, Xiang Y, Yang S-X, Zhang H-M, Li H, Zong Q-B, et al. MIR99AHG inhibits EMT in pulmonary fibrosis via the miR-136-5p/USP4/ACE2 axis. J Transl Med. 2022;20:426.CrossRef Wang J, Xiang Y, Yang S-X, Zhang H-M, Li H, Zong Q-B, et al. MIR99AHG inhibits EMT in pulmonary fibrosis via the miR-136-5p/USP4/ACE2 axis. J Transl Med. 2022;20:426.CrossRef
22.
Zurück zum Zitat Citrin DE, Shankavaram U, Horton JA, Shield W, Zhao S, Asano H, et al. Role of type II pneumocyte senescence in radiation-induced lung fibrosis. JNCI J Natl Cancer Inst. 2013;105:1474–84.CrossRef Citrin DE, Shankavaram U, Horton JA, Shield W, Zhao S, Asano H, et al. Role of type II pneumocyte senescence in radiation-induced lung fibrosis. JNCI J Natl Cancer Inst. 2013;105:1474–84.CrossRef
23.
Zurück zum Zitat Zhang H, Han G, Liu H, Chen J, Ji X, Zhou F, et al. The development of classically and alternatively activated macrophages has different effects on the varied stages of radiation-induced pulmonary injury in mice. J Radiat Res. 2011;52:717–26.CrossRef Zhang H, Han G, Liu H, Chen J, Ji X, Zhou F, et al. The development of classically and alternatively activated macrophages has different effects on the varied stages of radiation-induced pulmonary injury in mice. J Radiat Res. 2011;52:717–26.CrossRef
24.
Zurück zum Zitat Xu S, Xu H, Wang W, Li S, Li H, Li T, et al. The role of collagen in cancer: from bench to bedside. J Transl Med. 2019;17:309.CrossRef Xu S, Xu H, Wang W, Li S, Li H, Li T, et al. The role of collagen in cancer: from bench to bedside. J Transl Med. 2019;17:309.CrossRef
25.
Zurück zum Zitat Chanput W, Mes JJ, Savelkoul HFJ, Wichers HJ. Characterization of polarized THP-1 macrophages and polarizing ability of LPS and food compounds. Food Funct. 2013;4:266–76.CrossRef Chanput W, Mes JJ, Savelkoul HFJ, Wichers HJ. Characterization of polarized THP-1 macrophages and polarizing ability of LPS and food compounds. Food Funct. 2013;4:266–76.CrossRef
26.
Zurück zum Zitat Ti D, Hao H, Tong C, Liu J, Dong L, Zheng J, et al. LPS-preconditioned mesenchymal stromal cells modify macrophage polarization for resolution of chronic inflammation via exosome-shuttled let-7b. J Transl Med. 2015;13:308.CrossRef Ti D, Hao H, Tong C, Liu J, Dong L, Zheng J, et al. LPS-preconditioned mesenchymal stromal cells modify macrophage polarization for resolution of chronic inflammation via exosome-shuttled let-7b. J Transl Med. 2015;13:308.CrossRef
27.
Zurück zum Zitat Balli D, Ustiyan V, Zhang Y, Wang I-C, Masino AJ, Ren X, et al. Foxm1 transcription factor is required for lung fibrosis and epithelial-to-mesenchymal transition. EMBO J. 2013;32:231–44.CrossRef Balli D, Ustiyan V, Zhang Y, Wang I-C, Masino AJ, Ren X, et al. Foxm1 transcription factor is required for lung fibrosis and epithelial-to-mesenchymal transition. EMBO J. 2013;32:231–44.CrossRef
28.
Zurück zum Zitat Judge JL, Owens KM, Pollock SJ, Woeller CF, Thatcher TH, Williams JP, et al. Ionizing radiation induces myofibroblast differentiation via lactate dehydrogenase. Am J Physiol-Lung Cell Mol Physiol. 2015;309:L879–87.CrossRef Judge JL, Owens KM, Pollock SJ, Woeller CF, Thatcher TH, Williams JP, et al. Ionizing radiation induces myofibroblast differentiation via lactate dehydrogenase. Am J Physiol-Lung Cell Mol Physiol. 2015;309:L879–87.CrossRef
29.
Zurück zum Zitat Nguyen HQ, To NH, Zadigue P, Kerbrat S, De La Taille A, Le Gouvello S, et al. Ionizing radiation-induced cellular senescence promotes tissue fibrosis after radiotherapy a review. Crit Rev Oncol Hematol. 2018;129:13–26.CrossRef Nguyen HQ, To NH, Zadigue P, Kerbrat S, De La Taille A, Le Gouvello S, et al. Ionizing radiation-induced cellular senescence promotes tissue fibrosis after radiotherapy a review. Crit Rev Oncol Hematol. 2018;129:13–26.CrossRef
30.
Zurück zum Zitat Shimura T, Sasatani M, Kawai H, Kamiya K, Kobayashi J, Komatsu K, et al. Radiation-induced myofibroblasts promote tumor growth via mitochondrial ROS–activated TGFβ signaling. Mol Cancer Res. 2018;16:1676–86.CrossRef Shimura T, Sasatani M, Kawai H, Kamiya K, Kobayashi J, Komatsu K, et al. Radiation-induced myofibroblasts promote tumor growth via mitochondrial ROS–activated TGFβ signaling. Mol Cancer Res. 2018;16:1676–86.CrossRef
31.
Zurück zum Zitat Cytlak UM, Dyer DP, Honeychurch J, Williams KJ, Travis MA, Illidge TM. Immunomodulation by radiotherapy in tumour control and normal tissue toxicity. Nat Rev Immunol. 2022;22:124–38.CrossRef Cytlak UM, Dyer DP, Honeychurch J, Williams KJ, Travis MA, Illidge TM. Immunomodulation by radiotherapy in tumour control and normal tissue toxicity. Nat Rev Immunol. 2022;22:124–38.CrossRef
32.
Zurück zum Zitat Liu Z, Lei X, Li X, Cai J-M, Gao F, Yang Y-Y. Toll-like receptors and radiation protection. Eur Rev Med Pharmacol Sci. 2018;22:31–9. Liu Z, Lei X, Li X, Cai J-M, Gao F, Yang Y-Y. Toll-like receptors and radiation protection. Eur Rev Med Pharmacol Sci. 2018;22:31–9.
33.
Zurück zum Zitat Paun A, Fox J, Balloy V, Chignard M, Qureshi ST, Haston CK. Combined Tlr2 and Tlr4 deficiency increases radiation-induced pulmonary fibrosis in mice. Int J Radiat Oncol Biol Phys. 2010;77:1198–205.CrossRef Paun A, Fox J, Balloy V, Chignard M, Qureshi ST, Haston CK. Combined Tlr2 and Tlr4 deficiency increases radiation-induced pulmonary fibrosis in mice. Int J Radiat Oncol Biol Phys. 2010;77:1198–205.CrossRef
34.
Zurück zum Zitat Yang C, Song C, Wang Y, Zhou W, Zheng W, Zhou H, et al. Re-Du-Ning injection ameliorates radiation-induced pneumonitis and fibrosis by inhibiting AIM2 inflammasome and epithelial-mesenchymal transition. Phytomedicine. 2022;102: 154184.CrossRef Yang C, Song C, Wang Y, Zhou W, Zheng W, Zhou H, et al. Re-Du-Ning injection ameliorates radiation-induced pneumonitis and fibrosis by inhibiting AIM2 inflammasome and epithelial-mesenchymal transition. Phytomedicine. 2022;102: 154184.CrossRef
35.
Zurück zum Zitat Zhou J, Wu P, Sun H, Zhou H, Zhang Y, Xiao Z. Lung tissue extracellular matrix-derived hydrogels protect against radiation-induced lung injury by suppressing epithelial–mesenchymal transition. J Cell Physiol J Cell Physiol. 2020;235:2377–88.CrossRef Zhou J, Wu P, Sun H, Zhou H, Zhang Y, Xiao Z. Lung tissue extracellular matrix-derived hydrogels protect against radiation-induced lung injury by suppressing epithelial–mesenchymal transition. J Cell Physiol J Cell Physiol. 2020;235:2377–88.CrossRef
36.
Zurück zum Zitat Cao K, Lei X, Liu H, Zhao H, Guo J, Chen Y, et al. Polydatin alleviated radiation-induced lung injury through activation of Sirt3 and inhibition of epithelial-mesenchymal transition. J Cell Mol Med. 2017;21:3264–76.CrossRef Cao K, Lei X, Liu H, Zhao H, Guo J, Chen Y, et al. Polydatin alleviated radiation-induced lung injury through activation of Sirt3 and inhibition of epithelial-mesenchymal transition. J Cell Mol Med. 2017;21:3264–76.CrossRef
37.
Zurück zum Zitat Zaidi A, Jelveh S, Mahmood J, Hill RP. Effects of lipopolysaccharide on the response of C57BL/6J mice to whole thorax irradiation. Radiother Oncol. 2012;105:341–9.CrossRef Zaidi A, Jelveh S, Mahmood J, Hill RP. Effects of lipopolysaccharide on the response of C57BL/6J mice to whole thorax irradiation. Radiother Oncol. 2012;105:341–9.CrossRef
38.
Zurück zum Zitat Thakur P, DeBo R, Dugan GO, Bourland JD, Michalson KT, Olson JD, et al. Clinicopathologic and transcriptomic analysis of radiation-induced lung injury in nonhuman primates. Int J Radiat Oncol. 2021;111:249–59.CrossRef Thakur P, DeBo R, Dugan GO, Bourland JD, Michalson KT, Olson JD, et al. Clinicopathologic and transcriptomic analysis of radiation-induced lung injury in nonhuman primates. Int J Radiat Oncol. 2021;111:249–59.CrossRef
39.
Zurück zum Zitat Klingberg F, Chow ML, Koehler A, Boo S, Buscemi L, Quinn TM, et al. Prestress in the extracellular matrix sensitizes latent TGF-β1 for activation. J Cell Biol. 2014;207:283–97.CrossRef Klingberg F, Chow ML, Koehler A, Boo S, Buscemi L, Quinn TM, et al. Prestress in the extracellular matrix sensitizes latent TGF-β1 for activation. J Cell Biol. 2014;207:283–97.CrossRef
40.
Zurück zum Zitat Klingberg F, Hinz B, White ES. The myofibroblast matrix: implications for tissue repair and fibrosis. J Pathol. 2013;229:298–309.CrossRef Klingberg F, Hinz B, White ES. The myofibroblast matrix: implications for tissue repair and fibrosis. J Pathol. 2013;229:298–309.CrossRef
41.
Zurück zum Zitat Farhood B, khodamoradi E, Hoseini-Ghahfarokhi M, Motevaseli E, Mirtavoos-Mahyari H, Eleojo Musa A, et al. TGF-β in radiotherapy: Mechanisms of tumor resistance and normal tissues injury. Pharmacol Res. 2020;155:104745.CrossRef Farhood B, khodamoradi E, Hoseini-Ghahfarokhi M, Motevaseli E, Mirtavoos-Mahyari H, Eleojo Musa A, et al. TGF-β in radiotherapy: Mechanisms of tumor resistance and normal tissues injury. Pharmacol Res. 2020;155:104745.CrossRef
42.
Zurück zum Zitat Sun X-Y, Li H-Z, Xie D-F, Gao S-S, Huang X, Guan H, et al. LPAR5 confers radioresistance to cancer cells associated with EMT activation via the ERK/Snail pathway. J Transl Med. 2022;20:456.CrossRef Sun X-Y, Li H-Z, Xie D-F, Gao S-S, Huang X, Guan H, et al. LPAR5 confers radioresistance to cancer cells associated with EMT activation via the ERK/Snail pathway. J Transl Med. 2022;20:456.CrossRef
43.
Zurück zum Zitat Mandegary A, Saeedi A, Eftekhari A, Montazeri V, Sharif E. Hepatoprotective effect of silyamarin in individuals chronically exposed to hydrogen sulfide; modulating influence of TNF-α cytokine genetic polymorphism. DARU J Pharm Sci. 2013;21:28.CrossRef Mandegary A, Saeedi A, Eftekhari A, Montazeri V, Sharif E. Hepatoprotective effect of silyamarin in individuals chronically exposed to hydrogen sulfide; modulating influence of TNF-α cytokine genetic polymorphism. DARU J Pharm Sci. 2013;21:28.CrossRef
44.
Zurück zum Zitat Lei X, Du L, Yu W, Wang Y, Ma N, Qu B. GSTP1 as a novel target in radiation induced lung injury. J Transl Med. 2021;19:297.CrossRef Lei X, Du L, Yu W, Wang Y, Ma N, Qu B. GSTP1 as a novel target in radiation induced lung injury. J Transl Med. 2021;19:297.CrossRef
45.
Zurück zum Zitat Chodari L, Dilsiz Aytemir M, Vahedi P, Alipour M, Vahed SZ, Khatibi SMH, et al. Targeting mitochondrial biogenesis with polyphenol compounds. Oxid Med Cell Longev. 2021;2021:1–20.CrossRef Chodari L, Dilsiz Aytemir M, Vahedi P, Alipour M, Vahed SZ, Khatibi SMH, et al. Targeting mitochondrial biogenesis with polyphenol compounds. Oxid Med Cell Longev. 2021;2021:1–20.CrossRef
46.
Zurück zum Zitat Yin L, Liu X, Shao X, Feng T, Xu J, Wang Q, et al. The role of exosomes in lung cancer metastasis and clinical applications: an updated review. J Transl Med. 2021;19:312.CrossRef Yin L, Liu X, Shao X, Feng T, Xu J, Wang Q, et al. The role of exosomes in lung cancer metastasis and clinical applications: an updated review. J Transl Med. 2021;19:312.CrossRef
47.
Zurück zum Zitat Fan Y, Chen Z, Zhang M. Role of exosomes in the pathogenesis, diagnosis, and treatment of central nervous system diseases. J Transl Med. 2022;20:291.CrossRef Fan Y, Chen Z, Zhang M. Role of exosomes in the pathogenesis, diagnosis, and treatment of central nervous system diseases. J Transl Med. 2022;20:291.CrossRef
48.
Zurück zum Zitat Ahmadian E, Eftekhari A, Kavetskyy T, Khosroushahi AY, Turksoy VA, Khalilov R. Effects of quercetin loaded nanostructured lipid carriers on the paraquat-induced toxicity in human lymphocytes. Pestic Biochem Physiol. 2020;167: 104586.CrossRef Ahmadian E, Eftekhari A, Kavetskyy T, Khosroushahi AY, Turksoy VA, Khalilov R. Effects of quercetin loaded nanostructured lipid carriers on the paraquat-induced toxicity in human lymphocytes. Pestic Biochem Physiol. 2020;167: 104586.CrossRef
49.
Zurück zum Zitat Blanco E, Shen H, Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol. 2015;33:941–51.CrossRef Blanco E, Shen H, Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol. 2015;33:941–51.CrossRef
50.
Zurück zum Zitat Al-Lahham S, Rezaee F. Propionic acid counteracts the inflammation of human subcutaneous adipose tissue: a new avenue for drug development. Daru J Fac Pharm Tehran Univ Med Sci. 2019;27:645–52.CrossRef Al-Lahham S, Rezaee F. Propionic acid counteracts the inflammation of human subcutaneous adipose tissue: a new avenue for drug development. Daru J Fac Pharm Tehran Univ Med Sci. 2019;27:645–52.CrossRef
51.
Zurück zum Zitat Ma J, Hu W, Zhang D, Xie J, Duan C, Liu Y, et al. CD226 knockout alleviates high-fat diet induced obesity by suppressing proinflammatory macrophage phenotype. J Transl Med. 2021;19:477.CrossRef Ma J, Hu W, Zhang D, Xie J, Duan C, Liu Y, et al. CD226 knockout alleviates high-fat diet induced obesity by suppressing proinflammatory macrophage phenotype. J Transl Med. 2021;19:477.CrossRef
Metadaten
Titel
Monophosphoryl lipid A ameliorates radiation-induced lung injury by promoting the polarization of macrophages to the M1 phenotype
verfasst von
Xingdong Guo
Lehui Du
Na Ma
Pei Zhang
Yuan Wang
Yanan Han
Xiang Huang
Qian Zhang
Xin Tan
Xiao Lei
Baolin Qu
Publikationsdatum
01.12.2022
Verlag
BioMed Central
Erschienen in
Journal of Translational Medicine / Ausgabe 1/2022
Elektronische ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-022-03804-x

Weitere Artikel der Ausgabe 1/2022

Journal of Translational Medicine 1/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.